Neoadjuvant endocrine therapy of breast cancer: a surgical perspective
- 1 November 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (17) , 2214-2221
- https://doi.org/10.1016/s0959-8049(02)00265-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter studyAnnals of Oncology, 2001
- Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialJournal of Clinical Oncology, 2001
- Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast CancerBreast Cancer Research and Treatment, 2001
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of Clinical Oncology, 1997
- The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer.Breast Cancer Research and Treatment, 1997
- Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen onlyBritish Journal of Surgery, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Preoperative chemotherapy followed by mastectomy for locally advanced breast cancerJournal of Surgical Oncology, 1983
- Chemotherapy Before and After Mastectomy in Stage III Breast CancerArchives of Surgery, 1982